Yayın:
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon turkey study subgroup analysis

Basit Görünüm
dc.contributor.authorIşıkdoğan, A.
dc.contributor.authorTürk, H.
dc.contributor.authorBilir, C.
dc.contributor.authorSendur, M.
dc.contributor.authorKarabulut, B.
dc.contributor.authorArtaç, M.
dc.contributor.authorCicin, I.
dc.contributor.authorGeredeli, C.
dc.contributor.authorAlacacıoğlu, A.
dc.contributor.authorKefeli, U.
dc.contributor.authorHarputluoğlu, H.
dc.contributor.authorBozkurt, O.
dc.contributor.authorÇubukcu, E.
dc.contributor.authorTural, D.
dc.contributor.authorSakin, A.
dc.contributor.authorÇil, T.
dc.contributor.authorDane, F.
dc.contributor.authorÇevik, D.
dc.contributor.authorArslan, C.
dc.contributor.authorKaradurmuş, N.
dc.contributor.authorGümüş, M.
dc.contributor.authorYalçın, S.
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.departmentTıp Fakültesi
dc.contributor.researcheridETP-1691-2022
dc.date.accessioned2024-12-04T05:12:26Z
dc.date.available2024-12-04T05:12:26Z
dc.date.issued2022-06-01
dc.descriptionBu çalışma, 19 Haziran-02 Temmuz, 2022 tarihlerinde Barcelona[İspanya]’da düzenlenen ESMO 24. World Congress on Gastrointestinal Cancer Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Soc Med Oncol
dc.description.sponsorshipAmgen
dc.identifier.doi10.1016/j.annonc.2022.04.180
dc.identifier.eissn1569-8041
dc.identifier.endpageS281
dc.identifier.issn0923-7534
dc.identifier.startpageS281
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.04.180
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0923753422008705
dc.identifier.urihttps://hdl.handle.net/11452/48838
dc.identifier.volume33
dc.identifier.wos000823826500103
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherElsevier
dc.relation.journalAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.titleFirst-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon turkey study subgroup analysis
dc.typeOther
dc.type.subtypeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi
local.indexed.atWOS
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublication.latestForDiscoveryf971677f-09c5-4463-bf01-3c6341fbe5f7

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Çubukçu_vd_2022.pdf
Boyut:
103.29 KB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications